Skip to main content

University of Utah Research Foundation, Allergan

Premium
The University of Utah Research Foundation of Salt Lake City has been awarded US Patent 7,208,299, “Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces.”
 
Inventors listed on the patent are Karin Caldwell, Patrick Tresco, and Jennifer Neff.
 
The patent covers a composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces and hydrophobic coated surfaces. According to the patent abstract, “The composition is a biomolecule-conjugated end-group activated polymer. The biomolecule-conjugated EGAP can be put to numerous uses including cell adhesion, cell growth, cell sorting, and other biological assays.”
 

 
Allergan of Irvine, Calif, has been awarded US Patent 7,208,285, “FRET protease assays for botulinum serotype A/E toxins.”
 
Inventors listed on the patent are Lance Steward, Ester Fernandez-Salas, and Kei Roger Aoki
 
The patent covers clostridial toxin substrates that are useful in assaying for the protease activity of any clostridial toxin. The substrates contain, “a donor fluorophore; an acceptor having an absorbance spectrum overlapping the emission spectrum of the donor fluorophore; and a clostridial toxin recognition sequence that includes a cleavage site, where the cleavage site intervenes between the donor fluorophore and the acceptor and where, under the appropriate conditions, resonance energy transfer is exhibited between the donor fluorophore and the acceptor,” according the patent abstract.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.